Latest Breaking News On - Allschwil - Page 7 : comparemela.com

Basilea Pharmaceutica AG: Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Basilea Pharmaceutica AG: Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtComunidad autonoma de catalunaUnited statesVg fowler jrMarc engelhardtNils schrHuman servicesAdministration for strategic preparednessEuropean society of clinical microbiologyBasilea pharmaceutica international ltdBiomedical advanced researchDevelopment authoritySwiss exchangeBasilea pharmaceutica ltdDrug administration

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Allschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.

United statesSwitzerland generalBasel stadtComunidad autonoma de catalunaFowler jrMarc engelhardtNils schrBiomedical advanced researchHuman servicesUs department of healthHead of corporate communications investor relationsInternational journal of antimicrobial agentsBasilea pharmaceutica ltdDrug administrationSwiss exchangeBasilea pharmaceutica international ltd

Basilea Reports Presentation Of New Data For Ceftobiprole (Zevtera®) At ESCMID Global 2024

Basilea Reports Presentation Of New Data For Ceftobiprole (Zevtera®) At ESCMID Global 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaSwitzerland generalBasel stadtMarc engelhardtDrug administrationEuropean society of clinical microbiologyBasilea pharmaceutica ltdDevelopment authorityBiomedical advanced researchUs department of healthAdministration for strategic preparednessHuman servicesPharmaceutica ltdEuropean societyClinical microbiologyInfectious diseases

GNW-Adhoc: Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond ()

GNW-Adhoc: Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond () | aktiencheck.de

Switzerland generalUnited statesMartine clozelAndrewc weissIdorsia ltdHead of investor relations corporate communicationsIdorsia pharmaceuticals ltdSwiss exchangeChief financial officerDealer managerNorth americaVice presidentInvestor relationsPharmaceuticals ltdDes tages

newratings de

newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalAndrewc weissIhre freundeMartine clozelSwiss exchangeHead of investor relations corporate communicationsIdorsia ltdIdorsia pharmaceuticals ltdChief financial officerDealer managerNorth americaVice presidentInvestor relationsPharmaceuticals ltd